UK MHRA concludes inspection at Lupin’s Pithampur facilities in India

27 Mar 2023 Evaluate

UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) has successful completed inspection at Lupin’s Pithampur facilities in India. The inspection was conducted from March 20, 2023 to March 24, 2023. With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×